CRISPR Therapeutics (NASDAQ:CRSP) inventory has been falling over the previous month. With none milestone bulletins because it gained its second U.S. regulatory approval for its CASGEVY program in January, traders…
Tag:
Therapeutics
-
-
Investing
Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game? – TipRanks Financial Blog
by adminBeam Therapeutics (NASDAQ:BEAM) is a gene enhancing firm — one which will get much less consideration than its friends. Nonetheless, it at the moment has a $2.7 billion market cap…
-
Investing
Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results – TipRanks Financial Blog
by adminLead program in sufferers with lymphoma demonstrated preliminary security and efficacy outcomes with sustained full response in first research participant handled with MT-601 (Neldaleucel) following CAR T relapse Secured non-dilutive…
-